Results 21 to 30 of about 1,516,429 (359)

Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic

open access: yesGraefe's Archive for Clinical and Experimental Ophthalmology, 2020
Purpose There is an urgent need to address how to best provide ophthalmic care for patients with retinal disease receiving intravitreal injections with anti-vascular endothelial growth factor agents during the ongoing global COVID-19 pandemic.
J. Korobelnik   +14 more
semanticscholar   +1 more source

Comparison of suprachoroidal drug delivery with subconjunctival and intravitreal routes using noninvasive fluorophotometry. [PDF]

open access: yesPLoS ONE, 2012
To determine whether exposure of sodium fluorescein (NaF) to the choroid-retina region in the posterior segment of the eye is greater with suprachoroidal injection when compared to intravitreal and transscleral routes.Suprachoroidal injection, a new ...
Puneet Tyagi   +2 more
doaj   +1 more source

Incidence of endophthalmitis after intravitreal application of anti VEGF therapy at the University Clinical Center in Tuzla, Bosnia and Herzegovina [PDF]

open access: yesMedicinski Glasnik, 2015
Aim To report the incidence of endophthalmitis following the use of intravitreal injection of anti- vascular endothelial growth factor (anti VEGF) therapy.
Svjetlana Terzić   +2 more
doaj   +1 more source

The effects of intravitreal injections on intraocular pressure and retinal nerve fiber layer: a systematic review and meta-analysis

open access: yesScientific Reports, 2020
The number of eye diseases treated with intravitreal injections is increasing. Obviously, an injection of fluid into the eye results in an increase of intraocular pressure (IOP), the main risk factor for glaucoma.
Victor A de Vries   +2 more
semanticscholar   +1 more source

Intravitreal injections during COVID-19 outbreak: Real-world experience from an Italian tertiary referral center

open access: yesEuropean Journal of Ophthalmology, 2020
We report our experience during COVID-19 outbreak for intravitreal injections in patients with maculopathy. We proposed a treatment priority levels and timings; the “High” priority level includes all monocular patients; the “Moderate” is assigned to all ...
A. Carnevali   +5 more
semanticscholar   +1 more source

ACUTE MACULAR AND PERIPAPILLARY ANGIOGRAPHIC CHANGES WITH INTRAVITREAL INJECTIONS.

open access: yesRetina, 2020
PURPOSE Intravitreal injections acutely and temporarily increase intraocular pressure (IOP), and this may have cumulative long-term effects including an increased risk for glaucoma surgery.
A. Barash   +3 more
semanticscholar   +1 more source

Visual Acuity Prediction on Real-Life Patient Data Using a Machine Learning Based Multistage System [PDF]

open access: yes, 2022
In ophthalmology, intravitreal operative medication therapy (IVOM) is a widespread treatment for diseases related to the age-related macular degeneration (AMD), the diabetic macular edema (DME), as well as the retinal vein occlusion (RVO). However, in real-world settings, patients often suffer from loss of vision on time scales of years despite therapy,
arxiv   +1 more source

Embryonic Intravitreous Injection in Mouse [PDF]

open access: yesBIO-PROTOCOL, 2018
Axons of retinal ganglion cells (RGCs) relay visual information from the retina to lateral geniculate nucleus (LGN) and superior colliculus (SC), which are two major image-forming visual nuclei. Wiring of these retinal projections completes before vision begins.
Yupu Diao, Jiayi Zhang, Liyuan Cui
openaire   +4 more sources

Intravitreal Injections with Vascular Endothelial Growth Factor Inhibitors: A Practical Approach

open access: yesOphthalmology and Therapy, 2020
Intravitreal injections with vascular endothelial growth factor inhibitors constitute the most prevalent ophthalmic procedure in developed countries.
Anne-Sofie Petri   +7 more
semanticscholar   +1 more source

Intravitreal injections, antibiotics and endophthalmitis [PDF]

open access: yesEye, 2013
Sir, The article by Lyall et al1 entitled ‘Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors, and outcomes' is timely, given current efforts to minimize the risk of endophthalmitis following intravitreal injections.
A R Bhavsar   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy